RUNX2 and abnormal mineralization disorder: These findings indicate that CK2, by regulating the expression of RUNX2, decreases the bone turnover rate in CDK-MBD mice, enhances bone density and strength, and ameliorates Mineral and Bone Disorder in CKD-MBD mice.